English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

According to the World Health Organization, tuberculosis is still in the top ten causes of death from a single infectious agent, killing more than 1.7 million people worldwide each year. The rising resistance developed by  Mycobacterium tuberculosis  against currently used antituberculars is an imperative to develop new compounds with potential antimycobacterial activity. As a part of our continuous research on structural derivatives of the first-line antitubercular pyrazinamide, we have designed, prepared, and assessed the in vitro whole cell growth inhibition activity of forty-two novel 5-alkylamino- N -phenylpyrazine-2-carboxamides with various length of the alkylamino chain (propylamino to octylamino) and various simple substituents on the benzene ring. Final compounds were tested against  Mycobacterium tuberculosis  H37Ra and four other mycobacterial strains ( M. aurum ,  M. smegmatis ,  M. kansasii ,  M. avium ) in a modified Microplate Alamar Blue Assay. We identified several candidate molecules with micromolar MIC against  M. tuberculosis  H37Ra and low in vitro cytotoxicity in HepG2 cell line, for example,  N -(4-hydroxyphenyl)-5-(pentylamino)pyrazine-2-carboxamide ( 3c , MIC = 3.91 µg/mL or 13.02 µM, SI > 38) and 5-(heptylamino)- N -( p -tolyl)pyrazine-2-carboxamide ( 4e , MIC = 0.78 µg/mL or 2.39 µM, SI > 20). In a complementary screening, we evaluated the in vitro activity against bacterial and fungal strains of clinical importance. We observed no antibacterial activity and sporadic antifungal activity against the  Candida  genus.

5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation